Because apoC-II mimetic peptides could be a potential therapy for apoC-II deficiency, as well as possibly for other forms of HTG, it is important to establish in what tissues it promotes FFAs and TG metabolite uptake. The gene discussed is APOC2; the disease is hyperinsulinemic hypoglycemia, familial, 4.